Literature DB >> 24664877

Neurogenic bladder dysfunction presenting as urinary retention in neuronopathic Gaucher disease.

Erin R McNamara1, Jennifer Sullivan, Shashi K Nagaraj, John S Wiener, Priya S Kishnani.   

Abstract

Neuronopathic Gaucher disease can present as a continuum of clinical findings, including somatic symptoms of anemia, thrombocytopenia, hepatosplenomegaly, and bone disease as well as neurologic sequelae. There is a spectrum of neurologic symptoms ranging from oculomotor apraxia to severe convulsions. The heterozygosity of phenotypes makes it difficult to predict the disease course. We describe an 8-year-old male with neuronopathic type III Gaucher disease who developed bladder dysfunction and was unable to completely void. He also presented with hypertension and acute renal insufficiency, most likely secondary to urinary retention. A complete evaluation was done for causes of urinary retention and bladder dysfunction. A renal bladder ultrasound demonstrated marked hydroureteronephrosis. There was no clinical evidence of infection and cystoscopy revealed no anatomic obstruction. In addition, MRI showed no spinal abnormalities. His bladder dysfunction was managed operatively by creating a catheterizable stoma, using his appendix, to empty his bladder, and surgical findings were consistent with neurogenic bladder. He continues to be managed for his Gaucher disease and neurogenic bladder by genetics, nephrology and urology. This is the first clinical report of neurogenic bladder dysfunction in neuronopathic Gaucher disease.

Entities:  

Year:  2014        PMID: 24664877      PMCID: PMC4270873          DOI: 10.1007/8904_2014_299

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  5 in total

Review 1.  Management of neuronopathic Gaucher disease: a European consensus.

Authors:  A Vellodi; B Bembi; T B de Villemeur; T Collin-Histed; A Erikson; E Mengel; A Rolfs; A Tylki-Szymanska
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

2.  Phenotype, diagnosis, and treatment of Gaucher's disease.

Authors:  Gregory A Grabowski
Journal:  Lancet       Date:  2008-10-04       Impact factor: 79.321

3.  Novel pathologic findings associated with urinary retention in a mouse model of mucopolysaccharidosis type IIIB.

Authors:  Sylvia I Gografe; Paul R Sanberg; Wilfredo Chamizo; Hector Monforte; Svitlana Garbuzova-Davis
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

4.  Management of neuronopathic Gaucher disease: revised recommendations.

Authors:  A Vellodi; A Tylki-Szymanska; E H Davies; E Kolodny; B Bembi; T Collin-Histed; E Mengel; A Erikson; R Schiffmann
Journal:  J Inherit Metab Dis       Date:  2009-08-05       Impact factor: 4.982

5.  Neurogenic bladder in Hunter's syndrome.

Authors:  K Koyama; Y Moda; A Sone; H Tanaka; Y Hino
Journal:  J Med Genet       Date:  1994-03       Impact factor: 6.318

  5 in total
  2 in total

1.  Rapid Identification of New Biomarkers for the Classification of GM1 Type 2 Gangliosidosis Using an Unbiased 1H NMR-Linked Metabolomics Strategy.

Authors:  Benita C Percival; Yvonne L Latour; Cynthia J Tifft; Martin Grootveld
Journal:  Cells       Date:  2021-03-05       Impact factor: 6.600

2.  Low-Pressure, Low-Flow Voiding Dysfunction in an Elderly Male Treated Through Ayurveda: A Case Report.

Authors:  Sanjeev Rastogi
Journal:  J Evid Based Complementary Altern Med       Date:  2017-06-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.